Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.398
+0.017 (4.57%)
At close: Nov 4, 2024, 4:00 PM
0.386
-0.012 (-2.94%)
After-hours: Nov 4, 2024, 7:30 PM EST
Aptose Biosciences Employees
As of December 31, 2023, Aptose Biosciences had 36 total employees, including 35 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
36
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,119,278
Market Cap
6.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Zhongchao | 142 |
Check-Cap | 85 |
Healthcare Triangle | 31 |
Organovo Holdings | 20 |
TFF Pharmaceuticals | 19 |
Moleculin Biotech | 18 |
Galecto | 13 |
APTO News
- 2 months ago - Aptose Announces Results from Special Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib - GlobeNewsWire
- 2 months ago - Aptose Announces Adjournment of its Special Meeting of Shareholders - GlobeNewsWire
- 3 months ago - Aptose Reports Results for the Second Quarter 2024 - GlobeNewsWire
- 3 months ago - Aptose Announces Receipt of Deficiency Notice from Nasdaq - GlobeNewsWire
- 4 months ago - Aptose Announces Results from Annual and Special Meeting of Shareholders - GlobeNewsWire
- 5 months ago - Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress - GlobeNewsWire
- 5 months ago - Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire